Results 1 to 10 of about 966 (116)

经皮机械性血栓清除联合支架植入治疗髂静脉狭窄合并下肢深静脉血栓形成的中远期疗效 [PDF]

open access: yes浙江大学学报. 医学版
目的观察经皮机械性血栓清除(PMT)联合髂静脉支架植入治疗髂静脉狭窄合并下肢深静脉血栓形成的中远期疗效。方法收集2017年1月至2021年6月于浙北地区五家三级医院血管外科接受PMT联合髂静脉支架植入治疗的髂静脉狭窄合并下肢深静脉血栓形成总计125例患者的临床资料及随访信息,统计下肢血栓清除率、患肢血栓复发率、支架通畅率、下肢血栓后综合征(PTS)发生率,以及安全性评估指标如出血、死亡、肺栓塞、支架折断和移位等。结果125例患者中,下肢血栓清除程度Ⅰ级8例(6.4%),Ⅱ级10例(8.0 ...
陈 春伦   +5 more
doaj   +3 more sources

严重自发性脑出血患者术后下肢深静脉血栓形成的危险因素分析 Factors Related to the Deep Vein Thrombosis in Severe Spontaneous Intracerebral Hemorrhage Patients after Surgical Treatment

open access: yesZhongguo cuzhong zazhi, 2023
目的 为经手术治疗的严重自发性脑出血患者术后下肢深静脉血栓形成(deep vein thrombosis,DVT)风险判断和管理提供依据。 方法 回顾性分析2017年1月—2019年12月首都医科大学附属北京天坛医院神经外科经手术治疗的94例严重自发性脑出血患者的临床资料。根据出血后30 d内下肢深静脉超声结果,将患者分为DVT组和非DVT组,对比两组间的临床特点和术前影像学特点的差异。采用logistic回归分析探讨患者术后DVT的危险因素。 结果 94例患者中,19例(20.2 ...
方晓萌,袁巧玲,王硕
doaj   +2 more sources

急性脑出血患者下肢深静脉血栓形成的危险因素分析 Risk Factors of Lower Extremity Deep Vein Thrombosis in Patients with Acute Intracerebral Hemorrhage

open access: yesZhongguo cuzhong zazhi, 2023
目的 分析急性脑出血患者住院期间下肢深静脉血栓形成(deep venous thrombosis,DVT)发生率、发生时间及危险因素。 方法 选取首都医科大学附属北京天坛医院急性卒中入院后并发症队列研究中的脑出血患者,根据患者住院期间是否发生下肢DVT分为DVT组和无DVT组,比较两组患者的临床特征,采用多因素logistic回归分析脑出血患者发生DVT的危险因素。 结果 研究最终纳入314例脑出血患者,其中18例(5.7%)住院期间发生了DVT,发生脑出血至DVT确诊的中位时间为7.5(4.0 ...
郑昕, 郭军平, 张润华, 冀瑞俊
doaj   +2 more sources

Correlation between the Polymorphism of Coagulation-Related Genes and Lower Extremity Deep Venous Thrombosis [PDF]

open access: yes, 2021
Objective To investigate the correlation between the polymorphism of 4 coagulation-related genes, rs1799963 (coagulation factor V gene Leiden), rs6025 (prothrombin gene G20210A), rs1042579 (thrombomodulin protein gene c.1418C>T) and rs1801131 ...
JIANG Yao-ru, NIU Lei-lei, FENG Na, et al.
core   +1 more source

Effect of bundled care on prevention of lower extremity deep venous thrombosis in patients undergoing surgery for cerebral hemorrhage (集束化护理预防脑出血手术患者下肢深静脉血栓形成的效果)

open access: yes中西医结合护理, 2022
Objective To investigate the bundled care on prevention of lower extremity deep venous thrombosis (DVT) in patients undergoing surgery for cerebral hemorrhage. Methods Totally 40 patients undergoing surgery for cerebral hemorrhage were randomly divided
SHI Yanhua (时艳华)
doaj   +1 more source

运动训练促进脑卒中后神经可塑性的机制研究 [PDF]

open access: yes, 2021
运动训练是脑卒中后康复治疗的主要手段。运动训练可以促进脑卒中后神经功能的恢复,其作用目前普遍认为与神经可塑性有关,但具体机制未明。运动训练的神经可塑性机制是当前脑卒中康复研究领域的热点问题。运动训练可以调节脑卒中后脑内血流动力学变化、血管新生、神经炎症反应、营养因子分泌、神经细胞死亡及新生等。本文基于国内外研究,探讨脑卒中后最适的运动干预方案,并结合我们团队在运动训练促进脑卒中后神经功能恢复方向所做的系列研究工作 ...
胡昔权
core   +1 more source

Effect observation of Traditional Chinese Medicine acupoint application for patients with peripheral deep venous thrombosis of the lower extremity (穴位贴敷在周围型下肢深静脉血栓形成患者护理中的应用)

open access: yes中西医结合护理, 2022
Objective To investigate the effect of Traditional Chinese Medicine (TCM) acupoint application in relief of symptoms in patients with peripheral deep venous thrombosis of the lower extremity (LEDVT).
LIU Jinjing (刘津京)   +3 more
doaj   +1 more source

Practice of quality control circle activities in improving the standardized implementation rate of peripheral venous thrombolysis for lower-limb deep venous thrombosis (提高下肢深静脉血栓形成患者外周静脉溶栓执行规范率的品管圈实践)

open access: yes中西医结合护理, 2023
Objective To investigate the effect of quality control circle (QCC)activities in improving the standardized implementation rate of peripheral venous thrombolysis for lower-limb deep venous thrombosis (DVT). Methods A QCC group was set up.
BAI Mei (白枚)   +5 more
doaj   +1 more source

巴曲酶对急性下肢深静脉血栓形成的治疗价值观察 [PDF]

open access: yes, 2018
目的探讨巴曲酶对急性下肢深静脉血栓形成(DVT)的治疗价值。方法选取厦门大学附属第一医院2017年1月至2018年1月收治的114例急性下肢DVT患者,行链激酶治疗的为对照组,共57例,行巴曲酶治疗的为观察组,共57例,比较2组治疗有效率、不良发应发生率。结果观察组治疗有效率为94.74%(54/57),对照组治疗有效率为78.95%(45/57),2组比较差异具有统计学意义 ...
杨春源
core   +1 more source

Beliefs about medicines in patients with oral Rivaroxaban for the treatment of lower extremity deep venous thrombosis: A mixed-methods study (下肢深静脉血栓形成患者口服利伐沙班服药信念现状的混合研究)

open access: yes中西医结合护理, 2022
Objective To investigate the Beliefs about Medicines in patients with oral Rivaroxaban for the treatment of lower extremity deep venous thrombosis, and to provide evidence for improving the quality of anticoagulation.
YU Jie (于洁)   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy